NASDAQ: ADXN
Addex Therapeutics Ltd Stock Ownership - Who owns Addex Therapeutics?

Insider buying vs selling

Have Addex Therapeutics Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when ADXN insiders and whales buy or sell their stock.

ADXN Shareholders

What type of owners hold Addex Therapeutics Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Citadel Advisors LLC0.01%12,079$90.59kInstitution
Morgan Stanley0.00%1,900$14.25kInstitution
Gamma Investing LLC0.00%1,011$7.58kInstitution
Rhumbline Advisers0.00%107$802.50Institution
Sbi Securities Co Ltd0.00%5$37.50Institution
Concourse Financial Group Securities Inc0.00%0$0.00Institution

1 of 1

ADXN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ADXN0.02%0.00%
GNPX1.21%21.13%Net SellingNet Selling
BCLI1.19%98.81%Net Buying
LIPO0.53%69.70%Net Buying
LYRA40.81%15.59%

Addex Therapeutics Stock Ownership FAQ

Who owns Addex Therapeutics?

Addex Therapeutics (NASDAQ: ADXN) is owned by 0.02% institutional shareholders, 0.00% Addex Therapeutics insiders, and 99.98% retail investors. Citadel Advisors LLC is the largest individual Addex Therapeutics shareholder, owning 12,079.00 shares representing 0.01% of the company. Citadel Advisors LLC's Addex Therapeutics shares are currently valued at $90.59k.

If you're new to stock investing, here's how to buy Addex Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.